As of 31 May 2026, the administration and managed care agreements between Medscheme and Bonitas Medical Fund formally concluded.
The AfroCentric Group acknowledges this transition with sincere appreciation for the members, staff and stakeholders who have been part of this relationship, and with a clear commitment to what comes next.
The Transfer of Bonitas
In January 2026, Bonitas announced that it had awarded its administration contract to Momentum Health Solutions Proprietary Limited (Momentum) and its managed care contract to Private Health Administrators Proprietary Limited (PHA), with effect from 1 June 2026.
Medscheme’s administration of Bonitas ended formally on 31 May 2026. Notwithstanding the pending legal proceedings, Medscheme has cooperated fully and professionally throughout the transition process to ensure continuity of service for Bonitas members. The healthcare and administrative needs of Bonitas’ beneficiaries have been, and will continue to be, our overriding operational priority through this handover.
Following this transition milestone, a four-month wind-down period will commence for administration services and a two-month wind-down period for managed care services wherein Medscheme will continue to provide support to the new service provider with respect to query management.
From the 31 May 2026 cut-off date, Medscheme will no longer manage direct provider queries and as such, all provider-related queries and engagements must be directed to the new service providers through their support and communication channels.
Medscheme has ensured an orderly transition of all member records, clinical data and administrative systems to the incoming service providers. The interest of members of the Bonitas Medical Fund and uninterrupted access to their healthcare coverage and benefits continued to be our overarching priority throughout this transition process.
Our Position on the Legal Proceedings
AfroCentric and Medscheme wish to be transparent about the legal proceedings that have been filed, and about the principles that inform them.
We regard ourselves as reluctant litigants. Our legal action was not aimed at reversing a commercial decision or limiting Bonitas’ right to appoint a new service provider. Rather, it became necessary to take such action in response to sustained public allegations, documented concerns about governance and procurement processes at Bonitas, and the initiation of a Section 44 forensic investigation by the Council for Medical Schemes (CMS).
We attempted constructive engagement with Bonitas following media and whistleblower reports suggesting governance failures, undeclared conflict of interest and compromised procurement processes, however these efforts were not reciprocated. Legal action was neither our first nor was it our preferred course, it was pursued only as a last resort to protect the governance and integrity standards that underpin the entire medical scheme industry.
Medscheme filed an urgent High Court application on 15 December 2025, seeking to suspend the award of the RFPs or implementation thereof pending the CMS Section 44 investigation.
It is important to emphasise: the legal proceedings do not affect the quality or continuity of service Medscheme provides to any of its current clients. Our people, systems and clinical programmes are operating at full capacity and full commitment.
Our Response: Measured, Strategic, Forward-Looking
The conclusion of the Bonitas relationship represents a material change for AfroCentric. We have been transparent about that with our shareholders, our staff and our partners.
The Board of AfroCentric, with the full support of Sanlam has approved a structured response programme built around four priorities:
Structuring the business to reflect its new revenue reality, ensuring long-term financial sustainability.
02 Protecting
the core
Safeguarding the quality of service for the 3.3 million beneficiaries we continue to serve across our administered schemes.
03 Reorganising
the operating model
Building a lean, accountable structure that is fit for purpose and able to deliver to the highest standard for our existing client base.
04 Simplifying
the portfolio
Focusing on our core capabilities such as scheme administration, managed care and value-based care and removing complexity that does not deliver value.
Who We Remain
Medscheme continues to serve as the administrator and managed care partner to a substantial base of medical schemes, covering more than 3.3 million beneficiaries across South Africa. We carry that responsibility today with the same level of commitment that defined the first day of each of those relationships.
We remain one of the most clinically credentialed healthcare administrators in South Africa with deep expertise in value-based care, disease management, HIV/AIDS managed care through our AID for AIDS programme, pharmaceutical services and healthcare technology. We are building the future of healthcare administration, not merely defending the past.
Our relationship with Sanlam, and our role within the Sanlam Health Platform, continues to be a central pillar of our growth strategy. We are committed to the growth of all our administered schemes and delivering on Sanlam’s vision for integrated health and financial services in South Africa.